Venture Capital Investors

Juno Pharmaceuticals

VC investing group Juno Pharmaceuticals provides capital to innovative tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Juno Pharmaceuticals produces and distributes amoxicillin, hydrochloride syringes, hydromorphone solutions, phentermine tablets & capsules.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/10/2023

Transaction History

Our records indicate that Juno Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Managing Director

Mark Crotty

        

Chief Financial Officer

Paul Meulblok

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Juno Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Juno Capital Partners | Junsan Capital

Share this article

About Our VC Firm Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary